Neurological heterotopic ossification following spinal cord injury is triggered by macrophage-mediated inflammation in muscle

Journal of Pathology

Volumn 236, Issue 2, 2015, Pages 229-240

  Genêt, François ^a,b,c   Kulina, Irina ^a   Vaquette, Cedryck ^d   Torossian, Frédéric ^e,f   Millard, Susan ^a   Pettit, Allison R ^a   Sims, Natalie A ^g   Anginot, Adrienne ^e,f   Guerton, Bernadette ^e   Winkler, Ingrid G ^a   Barbier, Valérie ^a   Lataillade, Jean Jacques ^e,h   Le Bousse Kerdilès, Marie Caroline ^e,f   Hutmacher, Dietmar W ^a   Levesque, Jean Pierre ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^e INSERM   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^h Centre de Transfusion Sanguine des Armees   (France)

Author keywords

heterotopic ossification; inflammation; macrophage; spinal cord injury

Indexed keywords

5' NUCLEOTIDASE; CD45 ANTIGEN; CLODRONIC ACID; ENDOGLIN; LIPOSOME; NEUROKININ 1 RECEPTOR ANTAGONIST; PHOSPHATE; SUBSTANCE P; THY 1 ANTIGEN; ZOLEDRONIC ACID; CARDIOTOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HETEROTOPIC OSSIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; MYOSITIS; NEUROLOGIC DISEASE; NEUROLOGICAL HETEROTOPIC OSSIFICATION; NONHUMAN; OSSIFICATION; PARAPLEGIA; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SPINAL CORD INJURY; ANIMAL; C57BL MOUSE; COMPLICATION; CYTOLOGY; DISEASE MODEL; OSSIFICATION, HETEROTOPIC; PHYSIOLOGY; SKELETAL MUSCLE; STEM CELL;

ANIMALS; CARDIOTOXINS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MACROPHAGES; MICE, INBRED C57BL; MUSCLE, SKELETAL; MYOSITIS; OSSIFICATION, HETEROTOPIC; PARAPLEGIA; SPINAL CORD INJURIES; STEM CELLS;

EID: 84929287489     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4519     Document Type: Article

References (43)

1. Schurch B, Dollfus P,. The 'Dejerines': an historical review and homage to two pioneers in the field of neurology and their contribution to the understanding of spinal cord pathology. Spinal Cord 1998; 36: 78-86.
2. Forsberg JA, Pepek JM, Wagner S, et al., Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors. J Bone Joint Surg 2009; 91: 1084-1091.
3. Aubut JA, Mehta S, Cullen N, et al., A comparison of heterotopic ossification treatment within the traumatic brain and spinal cord injured population: an evidence-based systematic review. NeuroRehabilitation 2011; 28: 151-160.
4. Haran M, Bhuta T, Lee B,. Pharmacological interventions for treating acute heterotopic ossification. Cochrane Database Syst Rev 2004: CD003321.
5. Dizdar D, Tiftik T, Kara M, et al., Risk factors for developing heterotopic ossification in patients with traumatic brain injury. Brain Inj 2013; 27: 807-811.
6. Reznik JE, Biros E, Marshall R, et al., Prevalence and risk factors of neurogenic heterotopic ossification in traumatic spinal cord and traumatic brain-injured patients admitted to specialised units in Australia. J Musculoskelet Neuron Interact 2014; 14: 19-28.
7. Genet F, Jourdan C, Schnitzler A, et al., Troublesome heterotopic ossification after central nervous system damage: a survey of 570 surgeries. PLoS One 2011; 6: e16632.
8. Vanden Bossche L, Vanderstraeten G,. Heterotopic ossification: a review. J Rehabil Med 2005; 37: 129-136.
9. Bradleigh LH, Perkash A, Linder SH, et al., Deep venous thrombosis associated with heterotopic ossification. Arch Phys Med Rehabil 1992; 73: 293-294.
10. Salga M, Jourdan C, Durand MC, et al., Sciatic nerve compression by neurogenic heterotopic ossification: use of CT to determine surgical indications. Skel Radiol 2015; 42: 233-240.
11. Genet F, Chehensse C, Jourdan C, et al., Impact of the operative delay and the degree of neurologic sequelae on recurrence of excised heterotopic ossification in patients with traumatic brain injury. J Head Trauma Rehabil 2012; 27: 443-448.
12. Genet F, Marmorat JL, Lautridou C, et al., Impact of late surgical intervention on heterotopic ossification of the hip after traumatic neurological injury. J Bone Joint Surg Br 2009; 91: 1493-1498.
13. Kan L, Hu M, Gomes WA, et al., Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. Am J Pathol 2004; 165: 1107-1115.
14. Kan L, Kessler JA,. Animal models of typical heterotopic ossification. J Biomed Biotechnol 2011; 2011: 309287.
15. Shore EM, Xu M, Feldman GJ, et al., A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 2006; 38: 525-527.
16. Chakkalakal SA, Zhang D, Culbert AL, et al., An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva. J Bone Miner Res 2012; 27: 1746-1756.
17. Van Rooijen N, Sanders A,. Liposome-mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994; 174: 83-93.
18. Garret C, Carruette A, Fardin V, et al., Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci USA 1991; 88: 10208-10212.
19. + erythroid island macrophages in the mouse. Exp Hematol 2014; 42: 547-561.
20. Banovac K., The effect of etidronate on late development of heterotopic ossification after spinal cord injury. J Spinal Cord Med 2000; 23: 40-44.
21. Wick L, Berger M, Knecht H, et al., Magnetic resonance signal alterations in the acute onset of heterotopic ossification in patients with spinal cord injury. Eur Radiol 2005; 15: 1867-1875.
22. Jaovisidha S, Sartoris DJ, Martin EM, et al., Influence of heterotopic ossification of the hip on bone densitometry: a study in spinal cord injured patients. Spinal Cord 1998; 36: 647-653.
23. Rodriguez GP, Claus-Walker J, Kent MC, et al., Collagen metabolite excretion as a predictor of bone- and skin-related complications in spinal cord injury. Arch Phys Med Rehabil 1989; 70: 442-444.
24. Stover SL, Niemann KM, Tulloss JR,. Experience with surgical resection of heterotopic bone in spinal cord injury patients. Clin Orthop Relat Res 1991: 71-77.
25. Mitchell KJ, Pannerec A, Cadot B, et al., Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development. Nat Cell Biol 2010; 12: 257-266.
26. Montarras D, Morgan J, Collins C, et al., Direct isolation of satellite cells for skeletal muscle regeneration. Science 2005; 309: 2064-2067.
27. Dominici M, Le Blanc K, Mueller I, et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
28. Hruska KA, Mathew S,. The roles of the skeleton and phosphorus in the CKD mineral bone disorder. Adv Chronic Kidney Dis 2011; 18: 98-104.
29. Salisbury E, Rodenberg E, Sonnet C, et al., Sensory nerve-induced inflammation contributes to heterotopic ossification. J Cell Biochem 2011; 112: 2748-2758.
30. van Rooijen N, Hendrikx E,. Liposomes for specific depletion of macrophages from organs and tissues. Methods Mol Biol 2010; 605: 189-203.
31. Winkler IG, Sims NA, Pettit AR, et al., Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 2010; 116: 4815-4828.
32. Alexander KA, Chang MK, Maylin ER, et al., Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res 2011; 26: 1517-1532.
33. Sims NA, Martin TJ,. Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. BoneKEy Rep 2014; 3: 481.
34. Mitchell EJ, Canter J, Norris P, et al., The genetics of heterotopic ossification: insight into the bone remodeling pathway. J Orthop Trauma 2010; 24: 530-533.
35. Chang MK, Raggatt LJ, Alexander KA, et al., Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol 2008; 181: 1232-1244.
36. Raggatt LJ, Wullschleger ME, Alexander KA, et al., Fracture healing via periosteal callus formation requires macrophages for both initiation and progression of early endochondral ossification. Am J Pathol 2014; 184: 3192-3204.
37. Guihard P, Danger Y, Brounais B, et al., Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling. Stem Cells 2012; 30: 762-772.
38. Muller PA, Koscso B, Rajani GM, et al., Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility. Cell 2014; 158: 300-313.
39. Pirraco RP, Reis RL, Marques AP,. Effect of monocytes/macrophages on the early osteogenic differentiation of hBMSCs. J Tissue Eng Regen Med 2013; 7: 392-400.
40. Cadosch D, Toffoli AM, Gautschi OP, et al., Serum after traumatic brain injury increases proliferation and supports expression of osteoblast markers in muscle cells. J Bone Joint Surg 2010; 92: 645-653.
41. Gautschi OP, Cadosch D, Frey SP, et al., Serum-mediated osteogenic effect in traumatic brain-injured patients. ANZ J Surg 2009; 79: 449-455.
42. Asakura A, Komaki M, Rudnicki M,. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001; 68: 245-253.
43. Oishi T, Uezumi A, Kanaji A, et al., Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells. PLoS One 2013; 8: e56641.